Effectiveness and Duration of Effect of Open-Label Lisdexamfetamine Dimesylate in Adults With ADHD

Journal of Attention Disorders

Volumn 21, Issue 2, 2017, Pages 149-157

  Adler, Lenard A ^a,b   Lynch, Lauren R ^c   Shaw, David M ^a   Wallace, Samantha P ^d   O’Donnell, Katherine E ^a   Ciranni, Michael A ^e   Briggie, Alexis M ^f   Faraone, Stephen V ^g  

^a NEW YORK UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c FORDHAM UNIVERSITY   (United States)

^d HELP/Project Samaritan AIDS Services   (United States)

^e Adult Community Mental Health Services   (United States)

^f ADELPHI UNIVERSITY   (United States)

^g SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

ADHD; adult ADHD treatment; LDX

Indexed keywords

CENTRAL STIMULANT AGENT; LISDEXAMFETAMINE;

ADOLESCENT; ADULT; ATTENTION DEFICIT DISORDER; COMPARATIVE STUDY; CONTROLLED STUDY; CROSSOVER PROCEDURE; DELAYED RELEASE FORMULATION; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION; FEMALE; HUMAN; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; PSYCHOMETRY; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; SELF REPORT; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CROSS-OVER STUDIES; DELAYED-ACTION PREPARATIONS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LISDEXAMFETAMINE DIMESYLATE; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS; SELF REPORT; TREATMENT OUTCOME; YOUNG ADULT;

EID: 85008693016     PISSN: 10870547     EISSN: 15571246     Source Type: Journal    
DOI: 10.1177/1087054713485421     Document Type: Article

References (29)

1. Adler L. A., Cohen J., (2004). Diagnosis and evaluation of adults with attention-deficit/hyperactivity disorder. Psychiatric Clinics of North America, 27, 187-201.
2. Adler L. A., Goodman D. W., Kollins S. H., Weisler R. H., Krishnan S., Zhang Y... 303 Study Group. (2008). Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder. Journal of Clinical Psychiatry, 69, 1364-1373.
3. Adler L. A., Lynch L. R., Shaw D. M., Wallace S. P., O’Donnell K. E., Ciranni M. A., Faraone S. V., (2010, October). Effectiveness and duration of effect of open treatment in adult ADHD patients treated with lisdexamfetamine dimesylate-LDX. Paper presented at the 57th Annual Meeting of the American Academy of Child and Adolescent Psychiatry, New York, NY.
4. Adler L. A., Lynch L., Wallace S., Shaw D. M., Ciranni M., Sitt D. J., Faraone S. V., (2010, October). Adherence and treatment response in a trial of mixed amphetamine salts IR vs. XR in adult ADHD. Paper presented at the 57th Annual Meeting of the American Academy of Child and Adolescent Psychiatry, New York, NY.
5. Adler L. A., Spencer T., Faraone S. V., Kessler R. C., Howes M., Biederman J., Secnik K., (2006). Validity of pilot adult ADHD self-report scale (ASRS) to rate adult ADHD symptoms. Annals of Clinical Psychiatry, 18, 145-148.
6. Adler L. A., Spencer T., Faraone S. V., Reimherr F. W., Kelsey D., Michelson D., Biederman J., (2005). Training raters to assess adult ADHD: Reliability of ratings. Journal of Attention Disorders, 8, 121-126.
7. Adler L. D., Nierenberg A. A., (2010). Review of medication adherence in children and adults with ADHD. Postgraduate Medicine, 122(1), 184-191.
8. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text rev.). Washington, DC: Author.
9. Biederman J., Faraone S. V., (2005). Attention-deficit hyperactivity disorder. Lancet, 366, 237-248.
10. Biederman J., Spencer T., Wilens T., (2004). Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder. International Journal of Neuropsychopharmacology, 7, 77-97.
11. Cox D. J., Moore M., Burket R., Merkel R. L., Mikami A. Y., Kovatchev B., (2008). Rebound effects with long-acting amphetamine or methylphenidate stimulant medication preparations among adolescent male drivers with attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology, 18, 1-10.
12. Cronbach L. J., (1951). Coefficient alpha and the internal consistency of tests. Psychometrika, 16, 297-334.
13. DuPaul G. J., George J., Power T. J., Anastopoulos A. D., (1998). ADHD Rating Scale–IV: Checklists, norms, and clinical interpretation. New York, NY: Guilford.
14. Faraone S. V., Buitelaar J., (2010). Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis. European Child & Adolescent Psychiatry, 19, 353-364.
15. Faraone S. V., Glatt S. J., (2010). A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes. Journal of Clinical Psychiatry, 71, 754-763.
16. Faraone S. V., Wilens T. E., (2007). Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion. Journal of Clinical Psychiatry, 68(Suppl. 11), 15-22.
17. First M. B., Spitzer R. L., Gibbon M., Williams J., (2002). Structured Clinical Interview for DSM-IV-TR Axis I Disorders—Patient Edition (SCID-I/P). New York, NY: Biometrics Research Department, New York State Psychiatric Institute.
18. Kessler R. C., Adler L., Barkley R., Biederman J., Conners C. K., Demler O., Howes M. J., (2006). The prevalence and correlates of adult ADHD in the United States: Results from the National Comorbidity Survey Replication. American Journal of Psychiatry, 163, 716-723.
19. Najib J., (2009). The efficacy and safety profile of lisdexamfetamine dimesylate, a prodrug of d-amphetamine, for the treatment of attention-deficit/hyperactivity disorder in children and adults. Clinical Therapeutics, 31, 142-176.
20. Reimherr F. W., Marchant B. K., Strong R. E., Hedges D. W., Adler L., Spencer T. J., Soni P., (2005). Emotional dysregulation in adult ADHD and response to atomoxetine. Biological Psychiatry, 58, 125-131.
21. Sarampote C. S., Efron L. A., Robb A. S., Pearl P. L., Stein M. A., (2002). Can stimulant rebound mimic pediatric bipolar disorder? Journal of Child and Adolescent Psychopharmacology, 12, 63-67.
22. Spencer T. J., Adler L. A., McGough J. J., Muniz R., Jiang H., Pestreich L., & Adult ADHD Research Group. (2007). Efficacy and safety of dexmethylphenidate extended-release capsules in adults with attention-deficit/hyperactivity disorder. Biological Psychiatry, 61, 1380-1387.
23. Spencer T. J., Adler L. A., Weisler R. H., Youcha S. H., (2008). Triple-bead mixed amphetamine salts (SPD465), a novel, enhanced extended-release amphetamine formulation for the treatment of adults with ADHD: A randomized, double-blind, multicenter, placebo-controlled study. Journal of Clinical Psychiatry, 69, 1437-1448.
24. Weber J., Siddiqui M. A., (2009). Lisdexamfetamine dimesylate: In attention-deficit hyperactivity disorder in adults. CNS Drugs, 23, 419-425.
25. Wender P. H., (1995). Attention-deficit hyperactivity disorder in adults. New York, NY: Oxford University Press.
26. Wender P. H., Reimherr F. W., Wood D. R., (1981). Attention deficit disorder (“minimal brain dysfunction”) in adults. A replication study of diagnosis and drug treatment. Archives of General Psychiatry, 38, 449-456.
27. Wigal S. B., Kollins S. H., Childress A. C., Squires L., & 311 Study Group. (2009). A 13-hour laboratory school study of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorder. Child and Adolescent Psychiatry and Mental Health, 3(1), 17.
28. Wigal T., Brams M., Gasior M., Gao J., Squires L., Giblin J., & 316 Study Group. (2010). Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: Novel findings using a simulated adult workplace environment design. Behavioral and Brain Functions, 6(34). Retrieved from http://www.behavioralandbrainfunctions.com/content/6/1/34
29. Wilens T. E., Haight B. R., Horrigan J. P., Hudziak J. J., Rosenthal N. E., Connor D. F., Modell J. G., (2005). Bupropion XL in adults with attention-deficit/hyperactivity disorder: A randomized, placebo-controlled study. Biological Psychiatry, 57, 793-801.